Cue Financial Statements From 2010 to 2026

Cue Biopharma Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 63.3 M 37 M 41.9 M Slightly volatile Other Current Liabilities 3.2 M 3.4 M 2.2 M Slightly volatile Total Current Liabilities 10.6 M 15.7 M 7.3 M Slightly volatile Total Stockholder Equity 19.1 M 20.1 M 30.1 M Slightly volatile Other Liabilities 2.5 M 2.2 M 1.7 M Slightly volatile Net Tangible Assets 52.6 M 75.5 M 39.8 M Slightly volatile Property Plant And Equipment Net 6.3 M 5.6 M 4.2 M Slightly volatile Accounts Payable 2 M 3.2 M 1.4 M Slightly volatile Cash 45.3 M 25.8 M 30.3 M Slightly volatile Non Current Assets Total 8.5 M 8.1 M 5.8 M Slightly volatile Non Currrent Assets Other 2.2 M 2.5 M 1.5 M Slightly volatile Other Assets 2.1 M 3.9 M 1.7 M Slightly volatile Cash And Short Term Investments 52.9 M 26.9 M 34.9 M Slightly volatile Common Stock Total Equity 26.3 K 49.5 K 22.9 K Slightly volatile Common Stock Shares Outstanding 68 M 64.8 M 26.9 M Slightly volatile Liabilities And Stockholders Equity 63.3 M 37 M 41.9 M Slightly volatile Other Current Assets 974.7 K 925.8 K 648.2 K Slightly volatile Other Stockholder Equity 209.6 M 413.2 M 151.3 M Slightly volatile Total Liabilities 15.2 M 16.9 M 10.1 M Slightly volatile Deferred Long Term Liabilities 196.6 K 299.3 K 180.4 K Slightly volatile Property Plant And Equipment Gross 7.9 M 9.8 M 5.5 M Slightly volatile Total Current Assets 54.8 M 28.9 M 36.1 M Slightly volatile Common Stock 74.9 K 71.3 K 28.4 K Slightly volatile Property Plant Equipment 2.6 M 1.7 M 1.8 M Slightly volatile Short and Long Term Debt Total 11.1 M 10.2 M 6.8 M Slightly volatile Current Deferred Revenue 72.7 K 76.5 K 1.3 M Pretty Stable Net Receivables 1.4 M 1.1 M 1.1 M Slightly volatile Inventory 0.86 0.9 1.9 M Very volatile Net Invested Capital 18.7 M 19.6 M 54.5 M Slightly volatile Short and Long Term Debt 3.5 M 5 M 2.7 M Slightly volatile Net Working Capital 9.8 M 10.3 M 48.2 M Slightly volatile Short Term Debt 6.1 M 9.1 M 4.5 M Slightly volatile Intangible Assets 10 K 10.5 K 88.4 K Slightly volatile Capital Surpluse 237.6 M 363.6 M 185.9 M Slightly volatile Capital Stock 41.1 K 71.3 K 31.8 K Slightly volatile Capital Lease Obligations 5.8 M 4.1 M 6.2 M Pretty Stable Long Term Debt 4.9 M 3.8 M 7.1 M Slightly volatile Long Term Debt Total 6.4 M 7.2 M 7.9 M Slightly volatile
Cue Biopharma Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Selling General Administrative 12.1 M 16.8 M 8.3 M Slightly volatile Other Operating Expenses 42.1 M 58.4 M 29 M Slightly volatile Research Development 30 M 41.7 M 20.7 M Slightly volatile Total Operating Expenses 34.2 M 58.4 M 24.3 M Slightly volatile Net Interest Income 997.4 K 949.9 K 335.8 K Slightly volatile Interest Income 2 M 1.9 M 608.2 K Slightly volatile Non Operating Income Net Other 91.8 K 57.7 K 118.9 K Slightly volatile Selling And Marketing Expenses 2.1 M 3.3 M 1.7 M Slightly volatile
Cue Biopharma Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Total Cash From Financing Activities 11.2 M 11.8 M 21.3 M Pretty Stable End Period Cash Flow 45.4 M 26 M 30.4 M Slightly volatile Change To Netincome 7.4 M 10.9 M 5.4 M Slightly volatile Stock Based Compensation 7.8 M 7.9 M 5 M Slightly volatile Begin Period Cash Flow 47.7 M 56 M 31.3 M Slightly volatile Issuance Of Capital Stock 22.2 M 12.8 M 15.4 M Slightly volatile Dividends Paid 159.9 K 179.9 K 196.3 K Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 7.22 7.6 65.2387 Slightly volatile PTB Ratio 6.55 4.03 7.7472 Slightly volatile Days Sales Outstanding 40.58 42.71 75.7388 Slightly volatile Book Value Per Share 0.34 0.36 1.2972 Very volatile Average Payables 1.4 M 2.4 M 1.5 M Slightly volatile Stock Based Compensation To Revenue 0.81 0.85 4.3529 Slightly volatile PB Ratio 6.55 4.03 7.7472 Slightly volatile EV To Sales 5.62 5.92 51.31 Slightly volatile Inventory Turnover 1.49 1.67 1.8276 Slightly volatile Days Of Inventory On Hand 157 177 193 Slightly volatile Sales General And Administrative To Revenue 1.72 1.81 7.0178 Slightly volatile Research And Ddevelopement To Revenue 4.27 4.49 17.4865 Slightly volatile Capex To Revenue 0.0078 0.0082 0.8845 Slightly volatile Cash Per Share 0.45 0.48 1.3693 Very volatile Income Quality 0.62 0.8 0.7925 Slightly volatile Intangibles To Total Assets 2.0E-4 2.0E-4 0.0013 Slightly volatile Net Debt To EBITDA 0.4 0.42 1.879 Slightly volatile Current Ratio 2.01 2.11 10.5042 Slightly volatile Tangible Book Value Per Share 0.34 0.36 1.2967 Very volatile Receivables Turnover 6.19 8.84 6.0426 Slightly volatile Shareholders Equity Per Share 0.34 0.36 1.2972 Very volatile Debt To Equity 0.48 0.46 0.1735 Slightly volatile Capex Per Share 0.0013 0.0013 0.0502 Slightly volatile Graham Net Net 0.18 0.19 1.0671 Pretty Stable Average Receivables 2.1 M 1.8 M 2.1 M Slightly volatile Revenue Per Share 0.13 0.15 0.1091 Slightly volatile Interest Debt Per Share 0.24 0.15 0.2118 Slightly volatile Debt To Assets 0.26 0.25 0.1125 Slightly volatile Operating Cycle 40.58 42.71 131 Slightly volatile Price Book Value Ratio 6.55 4.03 7.7472 Slightly volatile Ebt Per Ebit 1.09 1.13 1.0077 Slightly volatile Company Equity Multiplier 1.06 1.66 1.2515 Slightly volatile Long Term Debt To Capitalization 0.12 0.1018 0.1094 Pretty Stable Total Debt To Capitalization 0.32 0.3 0.13 Slightly volatile Debt Equity Ratio 0.48 0.46 0.1735 Slightly volatile Quick Ratio 2.01 2.11 10.5017 Slightly volatile Net Income Per E B T 1.11 1.16 1.0309 Slightly volatile Cash Ratio 1.79 1.89 9.8569 Slightly volatile Days Of Inventory Outstanding 157 177 193 Slightly volatile Days Of Sales Outstanding 40.58 42.71 75.7388 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.19 1.15 1.1986 Slightly volatile Price To Book Ratio 6.55 4.03 7.7472 Slightly volatile Fixed Asset Turnover 1.81 1.73 0.7137 Slightly volatile Debt Ratio 0.26 0.25 0.1125 Slightly volatile Price Sales Ratio 7.22 7.6 65.2387 Slightly volatile Asset Turnover 0.27 0.26 0.0828 Slightly volatile Price Fair Value 6.55 4.03 7.7472 Slightly volatile
Cue Biopharma Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 67.1 M 70.6 M 151.8 M Pretty Stable Enterprise Value 52.2 M 55 M 126.3 M Very volatile

Cue Fundamental Market Drivers

Cue Upcoming Events

About Cue Biopharma Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cue Biopharma is a strong investment it is important to analyze Cue Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cue Biopharma's future performance. For an informed investment choice regarding Cue Stock, refer to the following important reports:

How To Invest In Cue Details

Is Cue Stock a good investment? Details

What is Cue Biopharma's Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details